Huaren Pharmaceutical Co. Ltd. | Ownership
Companies that own Huaren Pharmaceutical Co. Ltd.
The Vanguard Group, Inc.
856,972
0.09%
0
0%
07/31/2018
GF Fund Management Co., Ltd.
466,189
0.05%
-1,146,996
0%
12/31/2017
SWS MU Fund Management Co., Ltd.
327,253
0.03%
-80,493
0.01%
12/31/2017
Harvest Fund Management Co., Ltd.
29,281
0%
-7,578
0%
12/31/2017
China Southern Asset Management Co., Ltd.
12,975
0%
-2,297,661
0%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
8,956
0%
-1,608
0%
12/31/2017
Morgan Stanley Huaxin Fund Management Co., Ltd.
0
0%
-187,140
0%
12/31/2017
Golden Eagle Asset Management Co., Ltd.
0
0%
-135
0%
12/31/2017
Soochow Asset Management Co., Ltd.
0
0%
-74,063
0%
12/31/2017
ICBC Credit Suisse Asset Management Co., Ltd.
0
0%
-1,033,337
0%
12/31/2017
| Address |
No. 187 Zhuzhou Road
Qingdao Shandong 266101
China
|
|
Employees
|
- |
| Website |
http://www.qdhuaren.com |
| Updated |
07/08/2019 |
| Huaren Pharmaceutical Co., Ltd. engages in development, manufacture, and sale of non polyvinyl chloride and non-PVC large capacity preparations. Its products include basic, therapeutic, and nutritional infusion categories. The company was founded on August 23, 2001 and is headquartered in Qingdao, China. |
